UNOMR addresses this gap with its patented serial nanopore sensor, capable of detecting protein modifications at the single-molecule level.
UNOMR has raised €162k across 1 funding round from 1 investor, most recently a round in Apr 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-04-15 | Other | €162k |
| Venture Kick |
| View deal → |
